Large-scale testing (Phase 3)Study completedNCT03562156
What this trial is testing
Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Who this might be right for
Recurrent Vulvovaginal Candidiasis
Mycovia Pharmaceuticals Inc. 438